The outcome of prostate cancer patients treated with curative intent strongly depends on survival after metastatic progression
Abstract Background Five-year survival in patients with localized prostate cancer (PCa) is nearly 100%, but metastatic disease still remains incurable. Clinical management of metastatic patients has become increasingly complex as novel therapeutic strategies have emerged. This study aims at evaluati...
Main Authors: | Mariarosa Pascale, Che Ngwa Azinwi, Barbara Marongiu, Gianfranco Pesce, Flavio Stoffel, Enrico Roggero |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-09-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-017-3617-6 |
Similar Items
-
The Role of Cytoreductive Radical Prostatectomy in the Treatment of Newly Diagnosed Low-volume Metastatic Prostate Cancer. Results from the Local Treatment of Metastatic Prostate Cancer (LoMP) Registry
by: Nicolaas Lumen, et al.
Published: (2021-07-01) -
Adverse effects of curative treatment of prostate cancer
by: Fridriksson, Jon Örn
Published: (2016) -
Prognostic Value of Local Treatment in Prostate Cancer Patients With Different Metastatic Sites: A Population Based Retrospective Study
by: Shengming Jin, et al.
Published: (2020-12-01) -
The role of metastasis-directed therapy and local therapy of the primary tumor in the management of oligometastatic prostate cancer
by: Jongchan Kim, et al.
Published: (2017-09-01) -
Observation with or without late radiotherapy is equivalent to early radiotherapy in high-risk prostate cancer after radical prostatectomy: A SEER-Medicare analysis on trends, survival outcomes, and complications
by: Young Suk Kwon, et al.
Published: (2021-06-01)